Delivery Order SPE2DB20D3103-SPE2DB22FN2V2
- Not listed
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML. The $1,157.00 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $2,704.00. The delivery order contract is for the supply of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, with a period of performance through May 24, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,733.00 firm fixed price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, to provide MULTIHANCE 529 MG/ML VIAL 20ML, a specialty pharmaceutical product. The delivery order has a ceiling value of $1,189.20 and a period of performance through April 5, 2024. This award is a child contract under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, also awarded by DLA, with a potential...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a potential value of $1,719.90 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceutical products and medical supplies to...
- This delivery order, valued at $11,702.00, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Multihance 529 mg/mL vial 20 mL, a contrast agent used in medical imaging procedures. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 1, 2025. The award was made without set-aside designation through competitive procurement by the Defense Logistics Agency (DLA), with performance to be fulfilled from the vendor's Conshohocken,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROHANCE 279.3 MG/ML VIAL 20ML medical supplies. The contract has a ceiling value of $3,840.40 and an ultimate completion date of November 27, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, as a delivery order contract with a firm fixed price pricing type. The award...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN2V2Delivery Order
This federal contract award is for the delivery of Multihance 529 mg/ml vial, 10 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has a ceiling value of $2,256.26 and was made on a firm fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/6/22 |